Journal of anesthesia · 2025
Comparison of cerebral oxygen saturation values determined by time-resolved spectroscopy and spatially resolved spectroscopy in pediatric patients with congenital heart disease.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suemori Tomohiko, Yamada Takashi, Nagano Tatsuya, Satoh Masaaki, Takeuchi Mamoru
Аннотация
PURPOSE: Time-resolved spectroscopy (TRS) has recently become clinically available and offers superior measurement accuracy over conventional spatially resolved spectroscopy (SRS). This study evaluated the feasibility of transitioning from the SRS-based INVOS 5100C to the TRS-based tNIRS-1 by comparing cerebral oxygen saturation measurements taken during pediatric cardiac surgery.
METHODS: We retrospectively analyzed data from 149 children (< 6 years) who had undergone cardiac surgery. We compared simultaneously measured cerebral tissue oxygen saturation (StO₂) (tNIRS-1) and regional cerebral oxygen saturation (rSO₂) (INVOS 5100C) after anesthesia induction. Both values were assessed against reference cerebral oxygen saturation (REF CX). Clinical decisions based on StO₂ and rSO₂ were also compared to current reference thresholds.
RESULTS: The Wilcoxon matched-pairs signed-rank test showed significantly lower StO₂ than rSO₂ (54.8 [48.9-61.0] vs. 69 [61-75], p < 0.0001); this observation was consistent across all age groups and cyanotic statuses. Bland-Altman analysis confirmed non-interchangeability (mean bias: - 13.1; limits: - 31.7 to 5.5). Compared with REF CX, rSO₂ more closely reflected true cerebral oxygenation (mean bias: - 5.7; limits: - 22.5 to 11.2) than StO₂ (mean bias: - 19.3; limits: - 36.5 to - 2.1). Most patients were classified as normal by rSO₂ but borderline by StO₂.
CONCLUSION: A transition from INVOS 5100C to tNIRS-1 is not currently feasible due to clinically significant discrepancies. Therefore, it may be appropriate to either select the device based on the specific measurement objectives or use both devices in a complementary manner.
METHODS: We retrospectively analyzed data from 149 children (< 6 years) who had undergone cardiac surgery. We compared simultaneously measured cerebral tissue oxygen saturation (StO₂) (tNIRS-1) and regional cerebral oxygen saturation (rSO₂) (INVOS 5100C) after anesthesia induction. Both values were assessed against reference cerebral oxygen saturation (REF CX). Clinical decisions based on StO₂ and rSO₂ were also compared to current reference thresholds.
RESULTS: The Wilcoxon matched-pairs signed-rank test showed significantly lower StO₂ than rSO₂ (54.8 [48.9-61.0] vs. 69 [61-75], p < 0.0001); this observation was consistent across all age groups and cyanotic statuses. Bland-Altman analysis confirmed non-interchangeability (mean bias: - 13.1; limits: - 31.7 to 5.5). Compared with REF CX, rSO₂ more closely reflected true cerebral oxygenation (mean bias: - 5.7; limits: - 22.5 to 11.2) than StO₂ (mean bias: - 19.3; limits: - 36.5 to - 2.1). Most patients were classified as normal by rSO₂ but borderline by StO₂.
CONCLUSION: A transition from INVOS 5100C to tNIRS-1 is not currently feasible due to clinically significant discrepancies. Therefore, it may be appropriate to either select the device based on the specific measurement objectives or use both devices in a complementary manner.